Photo by ospanali from unsplash
• The article refers to the STAT6 siRNA sequences as “proprietary” as they are covered by patents owned by SIRNA Ltd., a daughter company of Celixir PLC. The patents cover… Click to show full abstract
• The article refers to the STAT6 siRNA sequences as “proprietary” as they are covered by patents owned by SIRNA Ltd., a daughter company of Celixir PLC. The patents cover Europe, Australia, Canada, New Zealand, US, South Africa, and cover the sequences for any use including development and/or sale of research reagents (EP1725658, AU2005217200, CA2599524, NZ549915, US7,566,700 and ZA2006/07471 which are all national/regional phases of the Walker and Hopkin patent in ref. 22). The authors provided documentation to support these statements regarding ownership of the relevant patents.
Journal Title: PLoS ONE
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!